Allied Corp has announced several changes to its management. The newly appointed management team and directors bring deep knowledge in pharmaceutical compliance, strong expertise in operations and execution, and a track record of global market expansion within regulated industries.
Jim Smeeding – Chairman of the Board
A long-standing Board member, Jim is a Healthcare and Pharmacy executive with 45+ years of experience in hospital pharmacy, managed care services and clinical services design. An entrepreneur himself, he has successfully built and led several pharmaceutical companies from funding to sale and advises major pharma and medical device firms. A founder of the Center for Pharmacoeconomic Studies at the University of Texas College Of Pharmacy, Jim also served as an Executive Director of the National Association of Specialty Pharmacy (NASP).
Simon Langelier – Director
A seasoned multinational executive and board member, Simon has 40+ years experience in cannabis, tobacco and consumer goods. 30+ years of leadership experience at Philip Morris International (PMI), where he led market expansion, M&A and operational restructuring across Europe, Asia, the Middle East and Africa. Among other positions at PMI, he was Managing Director for Colombia, President EEMA and President Eastern Asia. Simon also served on the Board of Imperial Brands. His expertise in strategy and expansion across global markets in highly regulated industries will be invaluable for the execution of Allied's next phase of growth.
Abdul Musoke – Director
Abdul is a corporate strategist with expertise in market expansion, regulatory oversight and financial structuring. As Chief Strategy Officer at Afri Digital Media Corp, he leads strategic acquisitions and regulatory compliance across Africa. He also serves as Director at Albertine Nuts Uganda Ltd, overseeing finance and partnerships for a 500-acre macadamia orchard. Abdul's experience in regulatory economics, M&A, and multinational negotiations will be instrumental in guiding Allied's global expansion and operational scale-up.
Michael Moses – Chief Executive Officer
Michael has played a pivotal role in establishing Allied's long-term strategy and commercializing its medical cannabis products, laying a strong foundation for the business' next phase of growth. As Chief Business Development Officer, he launched the Company's commercial arm, rolled out the sales strategy, built the client pipeline and secured multi-year partnerships in key medical markets. He also led Allied's operational restructuring, including workflow optimization, governance and building a scalable structure to align production, sales and compliance. Michael, an experienced entrepreneur with an Engineering Masters and a background in consulting and investment management, previously founded and scaled an award-winning digital marketing B2B business.
For more information:
Allied Corp
allied.health